How the Shift to Telehealth Affected Health Care Methods for Patients With Diabetes


Mary Reed, DrPH, research scientist at Kaiser Permanente, discussed how COVID-19 forced health systems to shift primarily to telehealth, and the impact this had on patients with diabetes.

Pharmacy Times interviewed Mary Reed, DrPH, research scientist at Kaiser Permanente, on the subject of her 2021 ADA conference session, "Reimagining Diabetes Care in the Virtual World."

In this discussion, Reed discussed how patient care for diabetes moved to a virtual environment during the COVID-19 pandemic, requiring providers to essentially conduct a mandatory pilot of shifting to telehealth for outpatient care. Further, there were disparities across health systems in terms of preexisting telehealth tools in use, causing the shift to affect each facility differently.

Related Videos
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder -
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff -
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 -
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk -
Capsules medicine and white medicine bottles on table | Image Credit: Satawat -
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn -
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg -
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl -
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka -
Bottle and scattered pills on color background, top view | Image Credit: New Africa -
© 2024 MJH Life Sciences

All rights reserved.